Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Amy Tillman"'
Autor:
Katherine A. High, Kathleen Z Reape, Jean Bennett, Albert M. Maguire, Stephen R. Russell, Zi-Fan Yu, Bart P. Leroy, Francesca Simonelli, Amy Tillman, Arlene V. Drack, Daniel C. Chung
Publikováno v:
Ophthalmology. 128:1460-1468
Purpose To determine whether functional vision and visual function improvements after voretigene neparvovec (VN; Luxturna [Spark Therapeutics, Inc]) administration in patients with biallelic RPE65 mutation-associated inherited retinal disease are mai
Autor:
Jane Mallewa, Titus H. Divala, Edson Mwinjiwa, Amy Tillman, Matthew Downs, Felix A. Mkandawire, Randy G. Mungwira, Joep J. van Oosterhout, Matthew B. Laurens, Maxwell Kanjala, Miriam K. Laufer, Wongani Nyangulu, Christopher V. Plowe, Osward M. Nyirenda, Terrie E. Taylor, Nginache Nampota, Lufina Tsirizani Galileya
Publikováno v:
Clin Infect Dis
BackgroundDaily co-trimoxazole is recommended for African adults living with human immunodeficiency virus (HIV) irrespective of antiretroviral treatment, immune status, or disease stage. Benefits of continued prophylaxis and whether co-trimoxazole ca
Autor:
Amy Tillman, Katherine A. High, Daniel C. Chung, Jean Bennett, Albert M. Maguire, Kathleen Z Reape, Stephen R. Russell, Arlene V. Drack, Bart P. Leroy, Zi-Fan Yu
Publikováno v:
Abstracts.
Autor:
Amy Tillman, Kathleen A. Marshall, Maria C. Davis, Janet Wittes, J. Fraser Wright, Hannah Reichert, Bart P. Leroy, Julie Pappas, Jean Bennett, Zi-Fan Yu, Stephen R. Russell, Jennifer Wellman, Okan U. Elci, Katherine A. High, Albert M. Maguire, Sarah McCague, Francesca Simonelli, Daniel C. Chung
Publikováno v:
Ophthalmology. 126:1273-1285
Purpose To report the durability of voretigene neparvovec-rzyl (VN) adeno-associated viral vector–based gene therapy for RPE65 mutation–associated inherited retinal dystrophy (IRD), including results of a phase 1 follow-on study at year 4 and pha
Autor:
Xiaosong Zhu, Jean Bennett, Chris A. Johnson, Katie Wachtel, Jean Walshire, Zi Fan Yu, Julie Pappas, Taylor Kehoe, Elliott H. Sohn, Jennifer Wellman, Vinit B. Mahajan, Bart P. Leroy, Michelle T. Weckmann, Francesca Simonelli, Okan U. Elci, Dominique Cross, Amy Tillman, J. Fraser Wright, Lindsey A. George, Kathleen A. Marshall, Julia A. Haller, Maria C. Davis, Edwin M. Stone, Janet Wittes, Laura E. Dingfield, Dina Y. Gewaily, Sarah McCague, Leslie Raffini, Katherine A. High, Albert M. Maguire, Hannah Reichert, Arlene V. Drack, Daniel C. Chung, Wanda Pfeifer, F. Parker Hudson, Stephen R. Russell
Publikováno v:
The Lancet. 390:849-860
Background Phase 1 studies have shown potential benefit of gene replacement in RPE65-mediated inherited retinal dystrophy. This phase 3 study assessed the efficacy and safety of voretigene neparvovec in participants whose inherited retinal dystrophy
Autor:
Albert M, Maguire, Stephen, Russell, Jennifer A, Wellman, Daniel C, Chung, Zi-Fan, Yu, Amy, Tillman, Janet, Wittes, Julie, Pappas, Okan, Elci, Kathleen A, Marshall, Sarah, McCague, Hannah, Reichert, Maria, Davis, Francesca, Simonelli, Bart P, Leroy, J Fraser, Wright, Katherine A, High, Jean, Bennett
Publikováno v:
Ophthalmology
To report the durability of voretigene neparvovec-rzyl (VN) adeno-associated viral vector-based gene therapy for RPE65 mutation-associated inherited retinal dystrophy (IRD), including results of a phase 1 follow-on study at year 4 and phase 3 study a
Autor:
Peter F. Billingsley, Mary Carrington, Judith E. Epstein, Donna Tosh, Martha Sedegah, Amy Tillman, Natasha Kc, Minglin Li, Shon Remich, B. Kim Lee Sim, Elizabeth Saverino, Jun Huang, Arnel Belmonte, Richard C. Ruck, Kevin Hauns, Tao Li, Abraham G. Eappen, Debbie Padilla, Alexandra Singer, Anita Manoj, Robin Nielsen, Adam Ruben, Maria Belmonte, Lindsey S. Garver, Kara A. Moser, Silas A. Davidson, Sumana Chakravarty, Eric R. James, Harini Ganeshan, Jessica Case, Eileen Villasante, Thomas L. Richie, Tooba Murshedkar, Sharina Reyes, Stephen L. Hoffman, Joana C. Silva, April Stafford, James E. Moon, Patrick S. Twomey, Yonas Abebe, Esteban Abot, Susan Cicatelli, Jason A. Regules, Carlos S. Vasquez, Bradley Hickey, Kristopher M. Paolino, Anusha Gunasekera
Publikováno v:
JCI Insight. 2
BACKGROUND: A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine) controlled human malaria infection (CHMI) 3 weeks af
Autor:
Amy Tillman, Kathleen Z Reape, Katherine A. High, Stephen R. Russell, Albert M. Maguire, Jean Bennett, Zi-Fan Yu, Thomas Ciulla, Daniel C. Chung, Arlene V. Drack
Publikováno v:
Journal of American Association for Pediatric Ophthalmology and Strabismus. 23:e7